← All trials
NCT06205706
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 4, 2023
- Primary completion
- Jul 14, 2027
- Completion date
- Nov 7, 2028
- First posted
- Jan 16, 2024
- Last posted
- Jul 23, 2024
- Enrollment
- 104
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BioInvent International ABLead sponsor
- BioInvent International ABOfficial
- MerckCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.